(Q30833479)

20 August 2017

0 references

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin (English)

1 reference

20 August 2017

1 reference

1 reference

1

Frederick S Barrett

1 reference

20 August 2017

Matthew W Johnson

2

1 reference

PMCID

5203697

20 August 2017

Roland R Griffiths

series ordinal

3

1 reference

PMCID

5203697

20 August 2017

language of work or name

English

0 references

publication date

6 October 2015

1 reference

Journal of Psychopharmacology

20 August 2017

1 reference

20 August 2017

29

1 reference

20 August 2017

11

1 reference

20 August 2017

1182-1190

1 reference

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5203697

The Construction and Preliminary Validation of a Measure of Reported Mystical Experience

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F0269881115609019

Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F0269881115609019

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F0269881115609019

21 January 2018

Identifiers

DOI

10.1177/0269881115609019

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

PMCID

5203697